Iconic Labs plc

As of December 31, 2025, Iconic Labs plc carries a market capitalization of 34.71M, placing it among publicly traded companies globally. Its enterprise value stands at 361.43M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Iconic Labs plc has 13.88M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Iconic Labs plc maintains a current ratio of 0.00, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, Iconic Labs plc's stock has declined approximately 46.67% over the past 52 weeks. The 50-day moving average sits at 1.61, while the 200-day moving average is 1.76.

As of December 31, 2025, Iconic Labs plc holds 898,200.00 in cash and equivalents against 327.62M in total debt, resulting in a net debt position of 326.72M. Total book value stands at -423.21M, with working capital of -423.21M providing operational flexibility.

Iconic Labs plc's most recent stock split took place on August 30, 2023 with a 10000:1 split ratio.